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Virus spreadThe ORF3 protein of the pathogenic porcine circovirus 2 (PCV2) causes apoptosis of the virus-infected cells. In
PCV2-infected piglets, ORF3 induces B and CD4 T lymphocyte depletion and lymphoid organ destruction and
the ORF3-deﬁcient PCV2 is attenuated in its pathogenicity (Virology, 383 (2009), 338). In addition to its role in
causing the apoptosis of the immune cells, characteristic of the PCV2 infection associated disease conditions,
the ORF3 also plays a role in the systemic dissemination of the PCV2 infection. Our experiments here show
that ORF3 expedites the spread of the virus by inducing the early release of the virus from the infected cells.
Further, in PCV2-infected mice, the ORF3-induced apoptosis also aids in recruiting macrophages to
phagocytize the infected apoptotic cells leading to the systemic dissemination of the infection. The apoptotic
activity of the ORF3 of PCV2 hence lends advantage to the spread of the virus.y Group, Temasek Lifesciences
earch Link, Singapore 117604.
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Porcine circovirus 2 (PCV2) is the primary causative factor of post
weaning multisystemic wasting syndrome (PMWS) in Swine (Allan
et al., 1998; Ellis et al., 1998). Many other conditions like porcine
dermatitis and nephropathy syndrome (PDNS), congenital tremors
(CT) are also described to be associated with the PCV2 infection,
which are collectively known as porcine circovirus associated diseases
(PCVAD) (Gillespie et al., 2009). The PMWS primarily affects weanling
piglets at 3 to 15 weeks age and has a high morbidity rate of up to 60%
(Segales and Domingo, 2002). In the affected farms, the mortality
ranges from 15% to 20% and occasionally reaches up to 80%. The
PMWS is characterized by generalized lymphadenopathy, lympho-
cytic depletion and multinucleated giant cell formation in lymph
nodes, and lymphoid organ destruction, with inﬂammatory lesions in
multiple organs involving liver, kidney, lungs, which show histolog-
ical lesions of histiocytic inﬁltration (Allan et al., 2004). The PCV2
infection leads to the decrease in the lymphocyte counts and
development of a compromised immune status and is found as a
co-infection with other pathogens (Nielsen et al., 2003; Allan et al.,
2004; Darwich et al., 2002, 2004; Segales et al., 2004). The PCV2
genome encodes for three major open reading frames (ORF), which
code for the replication associated proteins (ORF1), capsid protein(ORF2), and an apoptosis inducing protein (ORF3), which is not
essential for the replication of the virus (Cheung, 2003; Liu et al.,
2005). The study of the virus by molecular and epidemiological
analysis, by various groups across the globe, points out two virus
associated factors related to the replication cycle of the virus;
polymorphisms in the capsid region of the virus and the ORF3
protein, which induces apoptosis in virus-infected cells (Cheung et al.,
2007; Finsterbusch and Mankertz, 2009; Kiupel et al., 2005; Timmusk
et al., 2008). The polymorphisms in the ORF2 protein could play a role
in the cellular entry of the virus, which is thought to be mediated by
the interaction of the capsid with cell surface Heparan Sulphate and
Chondroitin Sulphate (Misinzo et al., 2006). Alternatively, the ORF2
polymorphisms could also affect the dynamics of virus assembly or
the structural stability of the virus, which is known to have a high
degree of thermal stability (O'Dea et al., 2008). Thus polymorphisms
of ORF2 could lend a higher degree of ﬁtness to viruses carrying
certain “alleles” of ORF2. This is indeed reﬂected by the widespread
temporal distribution of certain PCV2 genotypes, based on ORF2,
observed in the epizootiological data (Cheung et al., 2007; Cortey et
al., 2010; Gagnon et al., 2007; Wiederkehr et al., 2009). The second
factor, the apoptosis induced by the ORF3, causes the loss of
lymphocytes and lymphoid organ destruction in PCV2-infected
piglets (Shibahara et al., 2000; Darwich et al., 2002; Nielsen et al.,
2003; Liu et al., 2005, 2006; Timmusk et al., 2008; Karuppannan et al.,
2009). The lymphocytes play a pivotal role in the development of the
PCV2 infection associated diseases. The development of the PMWS is
thought to be positively correlated with the proliferation of the
lymphocytes induced by vaccination or co-infection with other
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(Krakowka et al., 2001, 2007; Ladekjaer-Mikkelsen et al., 2002). The
replication of PCV2 in the lymphocytes eventually leads to their
apoptosis. However, infection of mutant PCV2, deﬁcient in ORF3,
expression does not cause lymphocyte depletion or PCV2 associated
pathogenesis in experimentally infected piglets, revealed by histo-
logical and systemic evidence (Karuppannan et al., 2009). The ORF3 of
the non-pathogenic PCV1 and the ORF3 of the pathogenic PCV2 share
less than 60% identity at the amino acid level. The ORF3 of PCV2
interacts with Pirh2, an E3 ligase involved in the ubiquitination of p53,
resulting in the decreased levels of Pirh2 and an increase in levels of
p53, and leading to apoptosis of the virus-infected cells (Liu et al.,
2007; Karuppannan et al., 2010). Our previous studies have shown
that SPF piglets inoculated with ORF3-deﬁcient PCV2 show a delay in
the onset of systemic viremia with a decreased level of peak viremia
compared with the wild-type PCV2 inoculated speciﬁc pathogen free
piglets (Karuppannan et al., 2010). We hypothesize that the apoptosis
induced by the ORF3 of PCV2 could also have a role in the rapid spread
of the virus, leading to high viral load, which is associated with the
development of PCV2 associated diseases. Any factor that enhances
the spread of the virus could increase its evolutionary ﬁtness. Indeed,
retrospective epidemiological analyses in Sweden have shown that
speciﬁc ORF3 based phylogroups of PCV2 virus are associated with
PCV2 induced disease (Timmusk et al., 2008). Here we examine the
role of PCV2 ORF3 in the systemic spread of the virus using in vitro and
in vivo experiments.
Results
Growth kinetics of wild-type PCV2 and ORF3-deﬁcient PCV2
Our earlier experiments, in vitro in PK-15 cells and in vivo in mice
and piglets, have shown that the growth kinetics of ORF3-deﬁcient
mutant PCV2 always lagged behind that of the wild-type PCV2 (Liu
et al., 2005, 2006; Karuppannan et al., 2009). In order to examine the
pattern of virus spread in the PK-15 cell culture, the kinetics of the
replication of the wild-type PCV2 virus and the ORF3 mutant PCV2
virus in PK-15 cells were measured by quantifying the viral genome
copy numbers using quantitative real-time PCR assay. Parallel cultures
of PK15 cells in 35-mm cell culture dishes were infected with PCV2 or
ORF3-deﬁcient PCV2 virus, at a multiplicity of infection (MOI) of 0.1.
The virus genome copy numbers in the infected cultures from the cell0
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Fig. 1. The wild-type PCV2 is released into the cell culture supernatant earlier than the ORF3
type PCV2 or mutant PCV2 at 18, 24, 36, 48, 72, and 96 h after infection were quantitated b
associated fraction and the cell free fraction were quantiﬁed separately (HPI; hours post infree supernatant, attached cells and the total virus copy numbers in
the supernatant along with the cells were separately quantiﬁed, at 18,
24, 36, 48, 72, and 96 h after infection. The results showed that the cell
free virus numbers in the wild-type PCV2-infected cells were higher
than in the ORF3 mutant PCV2-infected cultures (Fig. 1). This
difference was pronounced in the early time points after infection
compared with the later time points after infection. However, the cell
associated virus levels of the wild-type and ORF3 mutant PCV2 at
early time points were similar. The difference in the cell associated
virus levels between the two viruses increased after 36 h post
infection until they reached almost similar levels at 72 h post
infection. These results clearly show that the higher replication
kinetics of wild-type PCV2 is associated with a higher cell free virus at
the earlier time points after infection.
Role of ORF3-induced apoptosis in the spread of the virus
Many viruses are known to affect the apoptotic machinery of their
host cells in the course of enhancing their evolutionary ﬁtness
(Devireddy and Jones, 1999; Dey et al., 2002; Dobner et al., 1996;
Granja et al., 2004; Jeurissen et al., 1992; Noteborn et al., 1994;
Roulston et al., 1999). The ORF3 of the PCV2 induces apoptosis in the
infected cells (Liu et al., 2005). To examine the possible role of the
apoptotic function of ORF3 in the spread of virus, the PCV2 replication
kinetics were assayed in the presence of 50 μMof zVAD, a pan-caspase
inhibitor, which is known to block the p53 mediated apoptosis. The
apoptotic induction by ORF3, measured by quantifying the caspase 3
activity with a colorimetric assay, was inhibited by the zVAD and the
caspase 3 activity was similar in the ORF3 mutant PCV2 and in the
zVAD treated wild-type PCV2 infection (Fig. 2). The replication
kinetics of the wild-type PCV2 and the ORF3-deﬁcient PCV2 were
quantiﬁed in the presence of the inhibitor (Fig. 3). The results showed
that the cell free virus levels and total virus replication kinetics in the
wild-type PCV2-infected cells were reduced in the presence of the
inhibitor. However, the ORF3 mutant PCV2 did not show any change
in its original replication kinetics in the presence of the inhibitor and
especially, the cell free virus levels of the ORF3mutant PCV2were also
not affected by the inhibitor. Further, in the presence of the inhibitor
the replication kinetics of the wild-type PCV2 was similar to that of
the ORF3 mutant PCV2 indicating that the apoptotic activity of the
ORF3 contributes to the enhanced spread of the wild-type PCV2 to the
supernatant.48 72 96
HPI
-deﬁcient mutant PCV2.The copy number of the viral genome after infection with wild-
y real-time PCR. The viral genome copy numbers in the total cell culture or in the cell
fection).
Fig. 2. A, Expression levels of ORF3 inwild-type PCV2 and ORF3mutant PCV2 virus-infected PK-15 cells were assayed byWestern blot. pcDNA3.1 ORF3 expression plasmid transfected PK-15
cellswere used as a control. B, Caspase 3 activity induced by PCV2 is abolished by zVAD, a pan-caspase inhibitor. The ratio of caspase 3 activity in PK-15 cells at 18, 24, 36, 48, 72, and 96 h after
infection with wild-type PCV2, mutant PCV2, wild-type PCV2 in the presence of 50 μM zVAD and uninfected control, was measured using a colorimetric assay (HPI; hours post infection).
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Fig. 3. The release of PCV2 virus from the infected cells to the cell culture supernatant is inhibited in the presence of caspase inhibitor zVAD. The copy number of the viral genome
after infection with wild-type PCV2 or mutant PCV2 in the presence or absence of zVAD was quantitated by real-time PCR at 18, 24, 36, 48, 72, and 96 h after infection. The viral
genome copy numbers in the total cell culture and the cell free fraction were quantiﬁed separately (HPI; hours post infection).
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PCV1 is a non-pathogenic contaminant of the PK15 cell line and
has been well documented to be a persistent non lytic infection even
in other cell lines (Stevenson et al., 1999; Victoria et al., 2010). The
ORF3 of the PCV1 signiﬁcantly varies from the ORF3 of PCV2 and does
not cause apoptosis when expressed in cells (our unpublished
observations). A chimeric PCV1-2 viral genome with the ORF2, origin
of replication of the PCV1 and the ORF1, ORF3 of PCV2 was
constructed and the virus was regenerated. In the context of above
ﬁndings, an assay was performed to examine if in mixed infection of
the ORF3-deﬁcient PCV2 and the PCV1-2 chimeric virus, the ORF3 of
PCV2 expressed from the PCV1-2 chimeric virus can enable an early
spread of the ORF3mutant PCV2 virus to the cell free supernatant. The
ORF3-deﬁcient PCV2 was quantiﬁed by using primers speciﬁc for
PCV2 ORF2 by a quantitative PCR assay. The replication kinetics of the
ORF3 mutant PCV2 in mixed culture with the chimeric PCV1-2
expressing the PCV2 ORF3 was higher compared to the pure ORF3
mutant PCV2 infection (Fig. 4). The mixed culture with the PCV1-2
chimera displayed an early increase in the cell free virus levels of the
ORF3-deﬁcient PCV2 compared to the pure culture of ORF3-deﬁcient
PCV2, and this increase was reversed in the presence of 50 μMof zVAD
in mixed virus infection cultures, showing that the apoptosis induced
by the ORF3 is necessary for this spread of the virus into the cell free
supernatant. This again directly shows that ORF3 plays a role in the
exit of the virus from the infected cells.
Role of ORF3-induced apoptosis in the in vivo spread of the virus
We next wanted to examine if the ORF3-induced apoptosis plays a
role in the spread of the virus in an in vivo infection. Many reports have
shown that in vivo administration of zVAD in mice blocks p53 induced
apoptosis (Emamaullee et al., 2007; Nussbaum and Whitton, 2004;
Sarkar et al., 2006). To study the role of ORF3-induced apoptosis in PCV2
virus spread, four groups of BALB/c mice were inoculated with 105
TCID50 of wild-type PCV2 or ORF3-deﬁcient PCV2 virus in the presence
or absence of zVAD. The zVAD regimen used here has been previously
shown not to adversely affect the health of the mice or affect the
immune response of mice to viral infection (Nussbaum and Whitton,
2004). The systemic spread of the wild-type PCV2 virus, assayed by
serumviremia, was reduced in the presence of the zVAD (Fig. 5). On day0
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Fig. 4. The release of mutant PCV2 from the infected cells is enhanced by complementation o
PCV2 ormutant PCV2 in the presence of chimeric PCV1 expressing the ORF3 of PCV2, were qu
copy numbers in the total cell culture and the cell free fraction were quantiﬁed separately7 post infection the serum viremia could not be detected in the group
infected with wild-type virus in the presence of zVAD and at all
subsequent time points, the viremia in this groupwas less compared to
the group infected with wild-type PCV2 in the absence of zVAD.
However, the kinetics of systemic virus spread of the groups infected
with ORF3-deﬁcient PCV2 virus was not altered by the presence of the
inhibitor zVAD. These observations show that the apoptosis induced by
ORF3 plays a role in the systemic spread of the virus.
Role of macrophages in the spread of PCV2 viremia
Phagocytic cells play a central role in the clearance of apoptotic
cells (Erwig and Henson, 2008). The apoptosis induced by PCV2 ORF3
in infected cells could facilitate the macrophage mediated systemic
spread of the virus. Indeed, in the analysis of natural PCV2 infections
in piglets, with severe disease manifestation, macrophages have been
found to contain a high load of PCV2 virus and this has also been
correlated with a high level of systemic PCV2 viremia (Darwich et al.,
2004; Harding et al., 2008; Krakowka et al., 2002; Sanchez et al., 2004;
Stevenson et al., 2001; Wallgren et al., 2009). This phenomenon could
also be observed in mice models of PCV2 infection, where macro-
phages were found to contain PCV2 antigen (Kiupel et al., 2001).
When we examined the virus levels in macrophages in the infected
mice, the wild-type PCV2-infected mice displayed a higher level of
virus in the macrophages compared to ORF3-deﬁcient PCV2-infected
mice (Fig. 6). However, in the presence of zVAD, the wild-type
PCV2-infected mice showed lower virus levels in the macrophages,
comparable to the levels in mice infected with ORF3-deﬁcient PCV2
virus. The ORF3-deﬁcient virus-infected mice on the other hand did
not show any alteration in the virus levels in macrophages in the
presence of zVAD. These results show that the apoptosis induced by
ORF3 of PCV2 helps in enhancing the systemic spread of the virus by
increasing the uptake of the virus by macrophages.
The ability of macrophages to support the replication of PCV2 is a
debated issue (Yu et al., 2007; Perez-Martin et al., 2007; Sanchez et al.,
2004; Darwich et al., 2004; Vincent et al., 2003). We next examined if
the macrophages could support the replication of the virus or merely
serves to disseminate the virus. RNA was isolated from puriﬁed
CD11b-positive splenic cells from the different groups of mice and
were examined for the levels of PCV2 replicase mRNA. The results
showed that PCV2 replicase (ORF1) RNA expression could not be48 72 96
HPI
f the ORF3 expression. The copy number of the viral genome after infection with mutant
antitated by real-time PCR at 18, 24, 36, 48, 72 and 96 h after infection. The viral genome
(HPI; hours post infection).
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Fig. 5. The apoptosis induced by ORF3 of PCV2 enhances the spread of the virus in vivo. The serum viremia of mice infected with wild-type PCV2 or mutant PCV2 in the presence or
absence of zVAD was quantiﬁed using real-time PCR assay at 7, 14, 21, and 28 days after infection (DPI; days post infection).
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groups (data not shown). This shows that PCV2 does not replicate in
the macrophage cells, at least in the mice model of infection. Further,
previous studies have shown that TNFα levels are elevated in the
PMWS affected pigs and could contribute to the progression of the
disease (Sipos et al., 2005; Kim et al., 2006; Shi et al., 2010). The in
vitro infection of primary porcine alveolar macrophages with PCV2
also leads to an elevation of TNFα secretion (Chang et al., 2006).
Supporting this observation, intramuscular injection of the ORF3
expression plasmid in mice has been shown to cause mortality and a
signiﬁcant elevation in the TNFα levels (An et al., 2008).We examined
the levels of TNFαmRNA in the macrophages of mice in the different
groups. The wild-type PCV2-infected mice showed an elevated TNFα
mRNA level, relative to the mice infected with wild-type virus in the
presence of zVAD (Fig. 7). Mice infected with the ORF3 mutant PCV2,
in the presence or absence of zVAD, showed signiﬁcantly lower levels
of TNFα mRNA in the macrophages compared to the wild-type
PCV2-infected mice. This indicates that ORF3-induced apoptosis and
macrophage recruitment lead to elevated TNFα levels, which has been
linked with PMWS progression in PCV2-infected piglets.0
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Fig. 6. The apoptosis induced by ORF3 of PCV2 enhances the viral load in macrophages in
mutant PCV2 in the presence or absence of zVAD was quantiﬁed using real-time PCR assayDiscussion
Porcine circovirus 2 is theprincipal infectious agent implicated in the
development of PMWS and other PCVAD (Allan et al., 1998; Ellis et al.,
1998). The major virus associated factors that are implicated in the
spread and pathogenesis of the virus are the polymorphisms in the
capsid of the virus and the apoptosis induced by the ORF3 protein in the
virus-infected cells (Cheung et al., 2007; Timmusk et al., 2008;
Finsterbusch and Mankertz, 2009; Shibahara et al., 2000; Liu et al.,
2005, 2006; Timmusk et al., 2008;Karuppannanet al., 2009). Viruses are
genomic parasites that evolve to usurp cellular proteins and pathways
for their beneﬁt. Some viruses inhibit apoptosis in the host cells, while
others induce apoptosis (Devireddy and Jones, 1999; Dey et al., 2002;
Dobner et al., 1996;Granja et al., 2004; Jeurissenet al., 1992;Noteborn et
al., 1994; Everett andMcFadden, 1999). The PCV2 ORF3 protein induces
apoptosis in the infected cells in a p53-dependent manner (Liu et al.,
2005). The ORF3 protein interacts with Pirh2, an E3 ligase speciﬁc for
p53. This interaction leads to the sequestration of Pirh2 in the cytoplasm
and a decrease in its half-life, leading to the increased cellular levels of
p53 and apoptosis (Liu et al., 2007; Karuppannan et al., 2010). Our2821
DPI
infected mice. The virus load in macrophages of mice infected with wild-type PCV2 or
at 7, 14, 21, and 28 days after infection (DPI; days post infection).
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Fig. 7. ORF3 of PCV2 contributes to elevated TNFα expression in macrophages of infected mice. The relative expression level of TNFαmRNA in macrophages of mice infected with
wild-type PCV2 or mutant PCV2 in the presence or absence of zVAD was quantiﬁed using real-time PCR assay at 7, 14, 21, and 28 days after infection (DPI; days post infection).
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piglets showed an absence of lymphoid organ depletion and reduction
in lymphocyte counts in the course of theviral infection, usually found in
infections with wild-type PCV2 (Karuppannan et al., 2009). Further,
these studies showed delayed kinetics of systemic viremia in infections
with theORF3-deﬁcient PCV2 virus alongwith the reduction in the level
of peak systemic viremia compared to the wild-type PCV2 infection.
However, the ORF3 of PCV2 is not essential for the replication of the
virus both in vitro and in vivo (Liu et al., 2005, 2006). These observations
indicate that the apoptosis induced by the ORF3 of PCV2 may play a
role in enhancing the systemic spread of the virus without directly
affecting the replication of the virus. Here, we have examined the role of
ORF3-induced apoptosis in the spread of the virus using in vitro and in
vivo experiments.
Our in vitro experiments reported here show that the apoptosis
induced by theORF3 of PCV2 enables the earlier release of thewild-type
PCV2 virus to the cell free supernatant compared to the ORF3-deﬁcient
PCV2 virus (Figs. 1, 3). The released virus re-infects other cells, and this
ampliﬁcation cycle results in the observed enhancement in the
replication kinetics. The pan-caspase inhibitor zVAD inhibits the
apoptosis induced by the ORF3 protein and delays the release of the
wild-type PCV2 virus into to the cell free supernatant and leads to a
delayed virus replication kinetics (Figs. 2, 3). This is similar to the virus
release pattern and replication kinetics of the mutant PCV2 deﬁcient in
ORF3 expression. On the same note, the PCV1, which does not induce
apoptosis in the infected cells, is known as a persistent, un-evident virus
infection in cell lines of porcine origin (Stevenson et al., 1999), and
recently contamination of PCV1 has been observed even in cell lines
used for production of live attenuated vaccines for human use (Victoria
et al., 2010). Ultra-structural studies of PK-15 cells persistently infected
with PCV1 shows that the assembled virus accumulates as dense
para-crystalline arrays in the cytoplasm of the infected cells (Stevenson
et al., 1999). Our experiments here show that in the absence of theORF3,
themutant PCV2 also accumulates in the cytoplasmof the infected cells,
possibly until the replication of the virus overwhelms the cellular
homeostasis resulting in the release of the virus. In mixed infections
withORF3-deﬁcient PCV2 and the PCV1-2 chimeric virus expressing the
PCV2 ORF3, the replication kinetics of ORF3-deﬁcient PCV2 is increased
aided by the early release of cell free virus, and this increase is reversed
by the presence of zVAD (Fig. 4). Thus the ORF3-induced apoptosis of
PCV2-infected cells enhances the release of the virus and enables its
spread. Similarly, mice infected with wild-type PCV2 reveals a faster in
vivo spread compared to infection with ORF3-deﬁcient PCV2, as
measured by the serum viremia (Fig. 5). The higher rate of virus spread
of the wild-type PCV2 is reduced by the co-administration of zVAD, a
pan-caspase inhibitor that is known to block p53 induced apoptosiswhen administered in vivo. This shows that apoptosis induced by PCV2
ORF3 facilitates the in vivo spread of the virus. Supporting this view,
infection studies in mice and SPF piglets display lower virus replication
kinetics of ORF3-deﬁcient PCV2 comparedwith thewild-type PCV2 (Liu
et al., 2006; Karuppannan et al., 2009). Further in cases of natural
infections of PCV2 in piglets with high levels of serum viremia that
develop to PMWS, macrophages are found to contain a high viral
antigen load (Darwich et al., 2004; Harding et al., 2008; Krakowka et al.,
2002; Sanchez et al., 2004; Stevenson et al., 2001;Wallgren et al., 2009).
This was also observed in mice experimentally infected with PCV2,
which display a high viral load in macrophages (Kiupel et al., 2001).
However, whether the PCV2 actively replicates in the macrophages is a
debated issue, as some reports show the absence of the replicative form
of the viral genome and absence of nuclear antigenic signal in these cells
(Perez-Martin et al., 2007; Darwich et al., 2004; Vincent et al., 2003).
Macrophages along with other phagocytic cells bring about the
clearance of apoptotic cells (Erwig and Henson, 2008) and could
inadvertently expedite the systemic dissemination of the PCV2 virus by
engulﬁng virus-infected apoptotic bodies and transporting them to the
regional lymph nodes, which are thought to be initial sites for PCV2
replication in natural infection (Yu et al., 2007; Vincent et al., 2003). In
our observations, mice infected with wild-type PCV2 have a higher
viral load in the macrophages compared to mice infected with the
ORF3-deﬁcient PCV2 or the wild-type PCV2-infected mice treated with
zVAD (Fig. 6). This again shows a direct relationship between the PCV2
induced apoptosis and the spreadof the virus through themacrophages.
Further, the cytokine secretion by macrophages is known to be
inﬂuenced by the presence of apoptotic cells (Lucas et al., 2003).
Our observations here show that the macrophages in wild-type
PCV2-infected mice have an elevated level of TNFα (Fig. 7), which is
typically observed in PCV2-infected piglets with PMWS (Sipos et al.,
2005; Kim et al., 2006, Shi et al., 2010). This elevation of TNFα is not
observed in macrophages of mice infected with ORF3-deﬁcient PCV2.
The ORF3 mediated elevation of TNFα was also observed in other
studies, when plasmid expression vector encoding ORF3 was injected
into mice, leading to severe symptoms and death (An et al., 2008). The
signaling mechanism involved in this cytokine induction needs to be
further elucidated. In summary, the apoptosis induced by ORF3 of PCV2
hastens the exit of the virus from the infected cells, enables the
macrophage mediated systemic spread of the virus, and also inﬂuences
the cytokine secretion by the macrophages.
The role of virus induced apoptosis in the lymphocyte depletion
and the progression of PCV2 associated diseases has been reported in
many studies (Shibahara et al., 2000; Nielsen et al., 2003; Liu et al.,
2005, 2006; Timmusk et al., 2008; Karuppannan et al., 2009). Our
previous studies have shown that ORF3-induced apoptosis leads to
254 A.K. Karuppannan, J. Kwang / Virology 410 (2011) 248–256lymphocyte depletion in PCV2-infected mice and piglets (Liu et al.,
2006; Karuppannan et al., 2009). However, the role of apoptosis in
PCV2 pathogenesis has also been contested by other reports
(Mandrioli et al., 2004; Resendes et al., 2004). On the same note, a
recent report of ORF3-deﬁcient PCV2 infection in conventional PCV2
free piglets claims that apoptosis induced by ORF3 does not play a
signiﬁcant role in the pathogenicity of the virus; however, on the
contrary, their data shows reduced viral replication kinetics and lower
peak viremia level in the ORF3-deﬁcient PCV2-infected piglets
compared to wild-type PCV2-infected piglets, supporting our ﬁndings
(Juhan et al., 2010). Our observations here directly show that the
ORF3 mediated apoptosis expedites the exit of the virus from the
infected cells, which otherwise could be accumulated in the infected
cells. The apoptosis mediated by ORF3 also leads to the rapid systemic
dissemination of PCV2 infection by recruiting themacrophages, which
could seed the draining lymph nodes with the virus, accelerating the
progression of the viral spread. The ORF3, which is not directly
involved in the replication of the virus, thus plays an important role in
the systemic spread of the viral infection. The involvement of speciﬁc
immune cells in the systemic pathogenesis of the PCV2 could be
further explored in “knockout mice” lacking speciﬁc components of
the immune system. Further studies to examine the role of ORF3 in
the spread of PCV2 virus from one piglet to another are necessary, as
the ORF3may also enhance the shedding of the virus from piglets with
high serum viremia.
Materials and methods
Cell culture and viruses
The PK-15 cells are of porcine origin and free of PCV1 contami-
nation (Liu et al., 2005). The cells were maintained in minimal
essential medium supplemented with 5% heat inactivated fetal bovine
serum (FBS), 5% L-glutamine, 100U/ml of Penicillin G, and 100 μl/ml
streptomycin at 37 °C in a humidiﬁed 5% CO2 incubator.
The PCV2 BJW strain virus was used for the experiments (Liu et al.,
2005). The chimeric PCV1-2 virus was constructed by inserting the
ORF2 and origin of replication of the PCV1 (DQ472015) in place of its
PCV2 (BJW strain) counterparts. The viral genome was synthesized
from a commercial source (Genscript, USA) and the virus regenerated
as described previously (Liu et al., 2005).
The virus infections were performed in parallel cultures of PK-15
cells in 35-mm dishes containing 1 ml of cell culture media. Brieﬂy,
the cells were seeded overnight and infected at a multiplicity of
infection (MOI) of 0.1 with the indicated virus. At various time points
after the infection, the virus genomes in the cell culture supernatant
or in the attached cells or the total virus numbers were quantiﬁed as
follows. The cell culture supernatants along with the ﬂoating cells
were collected and the viral genome isolated with QIAamp DNA kit
(Qiagen) according to the manufacturer's instructions. The attached
cells were harvested separately by scrapping-off with a sterile cell-
scarper and re-suspended in 1 ml PBS and the viral genome isolated as
mentioned above. Alternatively the scraped cells were suspended in
the cell culture supernatant and the total viral genome in both the cell
free and cell associated compartments was isolated. The viral genome
copy numbers were enumerated using real-time quantitative PCR as
described below.
Quantitative real-time PCR
Brieﬂy, viral genomewas isolated using the QIAamp DNA (QIAGEN)
and the copy number was estimated by using LightCycler ® real-time
PCR machine (Roche Applied Sciences) and DyNAmo™ SYBR® Green
qPCR Kit (Finnzymes). The primers used were speciﬁc for ORF2 in the
PCV2 genome and ampliﬁed a 250-bp region. The primers and PCR
parameters used were the same as described earlier (Liu et al., 2006).Plasmids and transfection
The ORF3 of PCV2 BJW strain was cloned in pcDNA3.1+
expression vector at BamHI and XhoI restriction sites. The following
primers were used for the ampliﬁcation of the ORF3 gene. ORF3
forward 5′-CAGAGGATCCATGGTAACCATCCCACCACTTG-3′, ORF3 re-
verse 5′-CAGACTCGAGTTACTTATCGAGTGTGGAGCTC-3′. The PK-15
cells were transfected with the plasmid by using Transfectin reagent
(Biorad).
Western blot analysis
The whole-cell lysates from virus-infected or untreated PK15 cells
were resolved by 12% sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and blotted onto nitrocellulose mem-
branes (Biorad). The membranes were blocked for 1 h at room
temperature in blocking buffer TBST (20 mM Tris–HCl [pH 7.4],
150 mM NaCl, 0.1% Tween 20) containing 5% skim milk powder to
prevent nonspeciﬁc binding and then incubated with mouse
polyclonal anti-ORF3 antibody (Liu et al., 2005) or anti-ORF2 speciﬁc
mouse monoclonal antibody (8C2) at room temperature for 1 h. The
membranes were then washed three times with TBST and incubated
for 1 h at room temperature with horseradish peroxidase-conjugated
anti-mouse secondary antibody (DAKO) diluted in blocking buffer
(1:2000). After washing the membrane, the proteins were visualized
using Super Signal West Femto Chemiluminescent substrate (Pierce)
and Amersham Hyperﬁlm (GE Amersham).
Assay for caspase activity
For quantifying the apoptosis induction by ORF3 in PK-15 cells
after viral infection, a colorimetric assay speciﬁc for active caspase 3
was performed (caspACE assay system, PROMEGA) by following the
manufacturer's instructions. Brieﬂy, the cells were harvested at
different time points after virus infection using a sterile cell scraper,
washed in PBS, and resuspended in the supplied cell lysis buffer. The
lysate was used for the colorimetric assay, which measured the
cleavage of Ac-DVED-pNA substrate by active caspase 3. The caspase 3
activity in virus-infected cells was normalized to that of uninfected
PK-15 cells.
Mice infections studies
The experimental design consisted of four groups of 8-week-old
BALB/cmicewith sixteenmiceper group. Each groupofmicewashoused
in an individual room and handled separately. The mice were each
inoculated, both intranasally and intraperitoneally, with 105 50% tissue
culture infective doses of the PCV2. The zVADfmk (BD biosciences) was
dissolved in DMSO vehicle to a ﬁnal DMSO concentration of 20%. The
zVAD was administered intra peritoneally at the rate of 1 mg/dose, once
in 3 days, starting a day before the inoculation of the virus and was
continued up to 25 days post inoculation. The regimenwas adapted from
a previous study on Lymphocytic chorio meningitis virus (LCMV)
infection in BALB/c mice model, which showed that the zVAD does not
affect the course of the immune response against viral infection
(Nussbaum and Whitton, 2004). Four mice from each group were
sacriﬁced at 1-week intervals and 0.5 ml of peripheral blood was
collected from each mouse, for the estimation of viremia. The viral
genomice DNA was isolated using QIAamp Blood DNA kit as mentioned
above and quantiﬁed by real-time PCR. The spleen was dissected out for
the isolation of the macrophage lineage cells. To describe the procedure
brieﬂy, the spleen cellswere crushedout of the capsule and collected into
heparinized PBS and the RBCwere lysed using a commercial kit (UTI Lyse
kit, Dako) and the macrophages were subsequently isolated with micro
beads conjugated to mouse antiCD11b antibodies using magnetic cell
sorting kit (MACS, Miltenyi biotec) by following the manufacturer's
255A.K. Karuppannan, J. Kwang / Virology 410 (2011) 248–256instructions. Flow cytometric analysis showed that more than 95% of the
puriﬁed cellswere CD11b-positive. The isolated cellswereused to isolate
the total RNA using Trizol Reagent (Invitrogen) following the manufac-
turer's instructions. The isolated RNA was treated with RNAse free
DNAseI to remove any contaminated DNA. The levels of PCV2 Replicase
RNA were estimated from the reverse transcribed RNA by real-time
PCR using the following primers Rep forward 5′-GCGGCAGCACCTCG-3′
and Rep reverse GTC 5′-CTTCCTCATTACCCTCC-3′. The TNFα and GAPDH
mRNA levels in the RNA fraction, after being reverse transcribed,
were estimated by real-time PCR assay with the following primers;
TNFα forwardprimer5′-TGATCCGCGACGTGGAA-3′, TNFα reverseprimer
5′-ACCGCCTGGAGTTCTGGAA-3′, GAPDH forward primer 5′-GCACAGT-
CAAGGCCGAGAAT-3′, GAPDH reverse primer 5′-GCCTTCTCCATGGTGGT-
GAA-3′.Acknowledgments
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